Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Himmelev Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.9% 2.1% 1.2% 1.1% 1.0% 0.9% 11.4% 11.4%   Credit score (0-100)   72 69 82 84 87 88 21 21   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   0.8 0.3 149.6 280.4 304.0 606.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   9,425 10,601 12,447 13,223 13,382 14,691 0.0 0.0   EBITDA   1,750 2,088 3,242 2,428 1,516 2,206 0.0 0.0   EBIT   775 973 2,062 1,275 135 1,540 0.0 0.0   Pre-tax profit (PTP)   598.4 814.7 1,986.4 1,257.7 120.0 1,530.2 0.0 0.0   Net earnings   486.4 631.1 1,547.1 978.9 182.7 1,189.4 0.0 0.0   Pre-tax profit without non-rec. items   598 815 1,986 1,258 120 1,530 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,768 1,845 1,374 882 2,946 2,443 0.0 0.0   Shareholders equity total   537 830 2,032 2,666 2,503 3,693 3,642 3,642   Interest-bearing liabilities   4,395 2,539 710 55.1 1,375 27.5 0.0 0.0   Balance sheet total (assets)   7,016 5,472 6,090 4,672 5,562 5,955 3,642 3,642   Net Debt   3,299 2,509 637 -575 1,284 -1,122 -3,642 -3,642     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,425 10,601 12,447 13,223 13,382 14,691 0.0 0.0   Gross profit growth   0.0% 12.5% 17.4% 6.2% 1.2% 9.8% -100.0% 0.0%   Employees   0 20 23 23 23 23 0 0   Employee growth %   0.0% 0.0% 15.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,016 5,472 6,090 4,672 5,562 5,955 3,642 3,642   Balance sheet change%   0.0% -22.0% 11.3% -23.3% 19.0% 7.1% -38.8% 0.0%   Added value   1,749.6 2,087.5 3,241.9 2,428.2 1,287.4 2,206.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   3,065 -1,605 -2,220 -2,212 116 -1,169 -2,443 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.2% 9.2% 16.6% 9.6% 1.0% 10.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.3% 15.6% 35.8% 23.8% 2.8% 26.8% 0.0% 0.0%   ROI %   16.1% 23.5% 67.7% 46.9% 4.3% 40.7% 0.0% 0.0%   ROE %   90.5% 92.3% 108.1% 41.7% 7.1% 38.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   7.7% 15.2% 33.4% 57.1% 45.0% 62.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   188.5% 120.2% 19.6% -23.7% 84.7% -50.9% 0.0% 0.0%   Gearing %   817.8% 306.1% 34.9% 2.1% 54.9% 0.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.9% 4.6% 5.0% 6.4% 2.9% 2.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.2 0.6 1.0 0.4 0.8 0.0 0.0   Current Ratio   0.9 0.5 0.8 1.4 0.7 1.2 0.0 0.0   Cash and cash equivalent   1,096.4 30.9 73.2 629.7 90.8 1,149.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -210.1 -1,634.4 -967.5 725.9 -932.8 449.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 104 141 106 56 96 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 104 141 106 66 96 0 0   EBIT / employee   0 49 90 55 6 67 0 0   Net earnings / employee   0 32 67 43 8 52 0 0